Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Assessing our capability to predict the presence of respiratory diseases at the age of four using data available at one month of age

Xinyi Han, Lawrence E. K. Gray, View ORCID ProfileRobert K. Mahar, View ORCID ProfileJohn B. Carlin, View ORCID ProfileSarath Ranganathan, Peter J. Vuillermin, View ORCID ProfileDamjan Vukcevic
doi: https://doi.org/10.1101/2021.07.04.21259873
Xinyi Han
1School of Mathematics and Statistics, University of Melbourne, Parkville, Vic 3010, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lawrence E. K. Gray
2School of Medicine, Deakin University, Geelong, Vic, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert K. Mahar
3Melbourne School of Population and Global Health, University of Melbourne, Parkville, Vic 3010, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Robert K. Mahar
John B. Carlin
4Clinical Epidemiology and Biostatistics Unit, Murdoch Children’s Research Institute, Parkville, Vic 3052, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for John B. Carlin
Sarath Ranganathan
5Respiratory Diseases, Murdoch Children’s Research Institute, Parkville, Vic 3052, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sarath Ranganathan
Peter J. Vuillermin
2School of Medicine, Deakin University, Geelong, Vic, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Damjan Vukcevic
1School of Mathematics and Statistics, University of Melbourne, Parkville, Vic 3010, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Damjan Vukcevic
  • For correspondence: damjan.vukcevic{at}unimelb.edu.au
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Chronic respiratory diseases are often difficult to cure and are likely to originate early in life. Therefore, early identification of such diseases is of interest for early prevention.

We explored the potential to predict these almost from birth; using data at 1 month of age, we attempted to predict disease occurrence 4 years later in life. Our data came from the Barwon Infant Study; after cleaning and processing, we had measurements on 41 variables from 401 participants.

We considered three respiratory diseases: asthma, wheeze and hay fever. As predictors, we used a variety of information that would be available in a clinical setting. Of particular interest to our investigation was whether lung function measurements (newly available at such an early age) would helpfully improve predictive accuracy. We also investigated whether maternal smoking (previously associated with respiratory illnesses) is a helpful predictor.

Our methods included logistic regression as the main model, multiple imputation to deal with missing values, stepwise selection and LASSO to select variables, and cross-validation to assess performance. We measured predictive performance using AUC (area under the receiver operating characteristic curve), sensitivity and specificity.

Broadly, we found that the best models had only modest predictive power for each disease. For example, for asthma we achieved an AUC of 0.67, a sensitivity of 68% and a corresponding specificity of 63%. Performance for the other two diseases was similar.

We also found that our lung function measurements did not improve predictive performance; some-what surprisingly, this was also true for maternal smoking. The most useful predictors included, among others, family history of these diseases and variables relating to the size of the infants.

Given the modest performance of these models, our findings suggest that very early prediction of respiratory illnesses is still a challenging task.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The establishment and infrastructure for the Barwon Infant Study was funded by the Murdoch Children's Research Institute, Deakin University, and Barwon Health. Subsequent funding was provided by the National Health and Medical Research Council (NHMRC; grants APP607370, APP1009044, APP1029927, APP1024619, APP1030701, APP1076667, APP1147970); the Shepherd Foundation; the Jack Brockhoff Foundation; the Scobie Trust; the Shane O'Brien Memorial Asthma Foundation; the Our Women's Our Children's Fundraising Committee Barwon Health; the Rotary Club of Geelong; the Ilhan Food Allergy Foundation; Geelong Medical and Hospital Benefits Association; the Percy Baxter Charitable Trust; Perpetual Trustees; and Vanguard Investments Australia. In-kind support was provided by the Cotton On Foundation and CreativeForce. Research at the Murdoch Children's Research Institute is supported by the Victorian Government through the Operational Infrastructure Support Program.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Barwon Health HREC

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Barwon Infant Study (BIS) Investigator Team https://www.barwoninfantstudy.org.au/

Data Availability

For queries about the data, please contact the Barwon Infant Study at BIS{at}BarwonHealth.org.au

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted July 05, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Assessing our capability to predict the presence of respiratory diseases at the age of four using data available at one month of age
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Assessing our capability to predict the presence of respiratory diseases at the age of four using data available at one month of age
Xinyi Han, Lawrence E. K. Gray, Robert K. Mahar, John B. Carlin, Sarath Ranganathan, Peter J. Vuillermin, Damjan Vukcevic
medRxiv 2021.07.04.21259873; doi: https://doi.org/10.1101/2021.07.04.21259873
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Assessing our capability to predict the presence of respiratory diseases at the age of four using data available at one month of age
Xinyi Han, Lawrence E. K. Gray, Robert K. Mahar, John B. Carlin, Sarath Ranganathan, Peter J. Vuillermin, Damjan Vukcevic
medRxiv 2021.07.04.21259873; doi: https://doi.org/10.1101/2021.07.04.21259873

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Respiratory Medicine
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)